Anti-malaria drug produced from tobacco plants

Researchers have genetically engineered tobacco plants to produce the anti-malaria drug, Artemisinin.

Washington: Israeli researchers have genetically engineered tobacco plants to produce the anti-malaria drug, Artemisinin.

The scientists say their research could widen the drug`s availability to treat a disease that, in Africa alone, kills hundreds of thousands children annually.

Bureau report

By continuing to use the site, you agree to the use of cookies. You can find out more by clicking this link

Close